These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1821997)

  • 1. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test in first-episode schizophrenia.
    Cesková E; Kaspárek T; Zourková A; Prikryl R
    Neuro Endocrinol Lett; 2006 Aug; 27(4):433-7. PubMed ID: 16892008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S
    Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Crncević Z
    Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Types of alcoholic abstinence and the dexamethasone test].
    Burov IuV; Treskov VG; Vedernikova NN; Sheveleva OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):424-8. PubMed ID: 3577539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC
    Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dysfunction of the hypothalamic-pituitary-adrenal axis in adolescents after a suicide attempt].
    Gmitrowicz A; Kołodziej-Maciejewska H
    Psychiatr Pol; 2001; 35(5):803-18. PubMed ID: 11842612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood traumata, Dexamethasone Suppression Test and psychiatric symptoms: a trans-diagnostic approach.
    Faravelli C; Gorini Amedei S; Rotella F; Faravelli L; Palla A; Consoli G; Ricca V; Batini S; Lo Sauro C; Spiti A; Catena Dell'osso M
    Psychol Med; 2010 Dec; 40(12):2037-48. PubMed ID: 20132583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rorschach test and the positive and negative symptoms of schizophrenia].
    Basińska M; Rybakowski J
    Psychiatr Pol; 1991; 25(5):16-22. PubMed ID: 1821988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N; Mück-Seler D; Jakovljević M
    Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms.
    Bruce KR; Steiger H; Israël M; Groleau P; Ng Ying Kin NM; Ouellette AS; Sycz L; Badawi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):241-6. PubMed ID: 22575215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E; Buol C; Wiedemann K; Holsboer F
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.